• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非黏液性肺腺癌中核分裂和坏死的预后影响及与 IASLC 分级系统的相关性。

Prognostic impact of mitosis and necrosis in non-mucinous lung adenocarcinomas and correlation with IASLC grading system.

机构信息

Department of Pathology, Ege University School of Medicine, Bornova, İzmir, Turkey.

Department of Thoracic Surgery, Ege University Faculty of Medicine, İzmir, Turkey.

出版信息

Histol Histopathol. 2024 Jun;39(6):703-714. doi: 10.14670/HH-18-661. Epub 2023 Sep 5.

DOI:10.14670/HH-18-661
PMID:37724635
Abstract

BACKGROUND

In 2020, the International Lung Cancer Study Group (IASLC) Pathology Committee established a grading system for non-mucinous primary lung adenocarcinomas. This grading system is based on whether areas of high-grade patterns are present in more than 20% of the tumor. Parameters, such as necrosis, mitotic activity, lymphovascular invasion (LVI) and spread through air spaces (STAS), are excluded from evaluating the grading system.

METHODS

A total of 217 patients' lung resection materials for primary lung adenocarcinoma were re-reviewed using the IASLC grading system. Necrosis, mitotic activity, LVI status and STAS were also evaluated in the resection materials, aiming to demonstrate the relationship between these histopathological features and clinical outcome data.

RESULTS

At all stages, overall survival (OS) and recurrence-free survival (RFS) were related to grade (=0.011 and 0.024, respectively). Additionally, patients with necrosis were associated with worse OS and RFS (=0.002 and 0.048, respectively). When grade 2 and 3 tumors were analyzed individually, a significant relationship was found between necrosis and OS in grade 3 tumors (=0.002). Patients with a high mitotic count (≥10/10 high-power fields) had significantly worse OS (=0.046). The prevalence of LVI and STAS increased with grade; however, their prognostic significance has not been demonstrated.

CONCLUSIONS

The new grading system provides a highly efficient prognostic classification for survival. Necrosis and high mitotic count are important prognostic parameters for survival. Additionally, necrosis is a stage-independent prognostic factor for OS in grade 3 tumors, although no effect on prognosis can be demonstrated in grade 2 tumors.

摘要

背景

2020 年,国际肺癌研究协会(IASLC)病理学委员会为非黏液性原发性肺腺癌建立了一个分级系统。该分级系统基于高级别模式区域是否存在于超过 20%的肿瘤中。在评估分级系统时,排除了坏死、有丝分裂活性、脉管侵犯(LVI)和通过空气空间扩散(STAS)等参数。

方法

共重新审查了 217 例原发性肺腺癌肺切除标本,使用 IASLC 分级系统。还评估了切除标本中的坏死、有丝分裂活性、LVI 状态和 STAS,旨在展示这些组织病理学特征与临床结果数据之间的关系。

结果

在所有分期中,总生存期(OS)和无复发生存期(RFS)与分级相关(分别为=0.011 和 0.024)。此外,有坏死的患者 OS 和 RFS 较差(分别为=0.002 和 0.048)。当单独分析 2 级和 3 级肿瘤时,在 3 级肿瘤中,坏死与 OS 之间存在显著关系(=0.002)。有高有丝分裂计数(≥10/10 高倍视野)的患者 OS 显著较差(=0.046)。LVI 和 STAS 的患病率随分级而增加;然而,其预后意义尚未得到证实。

结论

新的分级系统为生存提供了一种高效的预后分类。坏死和高有丝分裂计数是生存的重要预后参数。此外,坏死是 3 级肿瘤中 OS 的独立于分期的预后因素,尽管在 2 级肿瘤中不能证明对预后有影响。

相似文献

1
Prognostic impact of mitosis and necrosis in non-mucinous lung adenocarcinomas and correlation with IASLC grading system.非黏液性肺腺癌中核分裂和坏死的预后影响及与 IASLC 分级系统的相关性。
Histol Histopathol. 2024 Jun;39(6):703-714. doi: 10.14670/HH-18-661. Epub 2023 Sep 5.
2
Novel Insights Into the International Association for the Study of Lung Cancer Grading System for Lung Adenocarcinoma.肺腺癌国际肺癌研究协会分级系统的新见解。
Mod Pathol. 2024 Jul;37(7):100520. doi: 10.1016/j.modpat.2024.100520. Epub 2024 May 21.
3
Prognostic impact of the IASLC grading system of lung adenocarcinoma: a systematic review and meta-analysis.肺腺癌 IASLC 分级系统的预后影响:系统评价和荟萃分析。
Histopathology. 2024 Jul;85(1):51-61. doi: 10.1111/his.15172. Epub 2024 Mar 14.
4
The role of extensive lymph node dissection in the new grading system for lung adenocarcinoma.广泛淋巴结清扫在肺腺癌新分级系统中的作用。
Eur J Surg Oncol. 2024 Oct;50(10):108540. doi: 10.1016/j.ejso.2024.108540. Epub 2024 Jul 10.
5
Architectural Grade Combined With Spread Through Air Spaces (STAS) Predicts Recurrence and is Suitable for Stratifying Patients Who Might Be Eligible for Lung Sparing Surgery for Stage I Adenocarcinomas.建筑分级结合气腔播散(STAS)可预测复发,适用于对可能适合I期腺癌肺保留手术的患者进行分层。
Pathol Oncol Res. 2020 Oct;26(4):2451-2458. doi: 10.1007/s12253-020-00855-7. Epub 2020 Jun 20.
6
Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea.韩国 TKI 时代的外科数据库研究:与 IASLC 浸润性非黏液性腺癌组织学分级系统相比,切除的浸润性黏液性腺癌的预后。
Thorac Cancer. 2022 Dec;13(23):3310-3321. doi: 10.1111/1759-7714.14687. Epub 2022 Nov 7.
7
Prognostic value of the international association for the study of lung cancer grading system and its association with the tumor microenvironment in stage I EGFR-muted lung adenocarcinoma.国际肺癌研究协会分级系统的预后价值及其与 I 期 EGFR 突变型肺腺癌肿瘤微环境的关系。
Eur J Cancer. 2024 Aug;207:114184. doi: 10.1016/j.ejca.2024.114184. Epub 2024 Jun 24.
8
Prognostic Impact of Histopathologic Features in Pulmonary Invasive Mucinous Adenocarcinomas.肺浸润性黏液腺癌的组织病理学特征对预后的影响。
Am J Clin Pathol. 2020 Jun 8;154(1):88-102. doi: 10.1093/ajcp/aqaa026.
9
High-grade tumor classified by new system is a prognostic predictor in resected lung adenocarcinoma.新系统分类的高级别肿瘤是肺腺癌切除术后的预后预测因子。
Gen Thorac Cardiovasc Surg. 2022 May;70(5):455-462. doi: 10.1007/s11748-021-01758-3. Epub 2022 Jan 20.
10
A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.一种结合了形态学特征和有丝分裂计数的分级系统可预测Ⅰ期肺腺癌的复发。
Mod Pathol. 2012 Aug;25(8):1117-27. doi: 10.1038/modpathol.2012.58. Epub 2012 Apr 13.

本文引用的文献

1
A Simplified Version of the IASLC Grading System for Invasive Pulmonary Adenocarcinomas With Improved Prognosis Discrimination.IASLC 肺浸润性腺癌分级系统简化版,提高了预后判别能力。
Am J Surg Pathol. 2023 Jun 1;47(6):686-693. doi: 10.1097/PAS.0000000000002040. Epub 2023 Apr 10.
2
The prognostic value of histopathology in invasive lung adenocarcinoma: a comparative review of the main proposed grading systems.浸润性肺腺癌的组织病理学预后价值:主要提出的分级系统比较综述。
Expert Rev Anticancer Ther. 2023 Mar;23(3):265-277. doi: 10.1080/14737140.2023.2179990. Epub 2023 Feb 20.
3
The IASLC Proposed Grading System Accurately Predicts Prognosis and Mediastinal Nodal Metastasis in Patients With Clinical Stage I Lung Adenocarcinoma.
IASLC 提出的分级系统可准确预测临床 I 期肺腺癌患者的预后和纵隔淋巴结转移。
Am J Surg Pathol. 2022 Dec 1;46(12):1633-1641. doi: 10.1097/PAS.0000000000001876. Epub 2022 Oct 13.
4
The new IASLC grading system for invasive non-mucinous lung adenocarcinoma is a more useful indicator of patient survival compared with previous grading systems.新的 IASLC 浸润性非黏液肺腺癌分级系统与既往分级系统相比,是一个更能预测患者生存的指标。
J Surg Oncol. 2023 Jan;127(1):174-182. doi: 10.1002/jso.27091. Epub 2022 Sep 13.
5
Validation Study of New IASLC Histology Grading System in Stage I Non-Mucinous Adenocarcinoma Comparing With Minimally Invasive Adenocarcinoma.新 IASLC 组织学分型系统在 I 期非黏液性腺癌中与微浸润性腺癌的验证研究
Clin Lung Cancer. 2022 Nov;23(7):e435-e442. doi: 10.1016/j.cllc.2022.06.004. Epub 2022 Jun 22.
6
A Novel Radiopathological Grading System to Tailor Recurrence Risk for Pathologic Stage IA Lung Adenocarcinoma.一种新型放射病理学分级系统,用于调整病理IA期肺腺癌的复发风险。
Semin Thorac Cardiovasc Surg. 2023;35(3):594-602. doi: 10.1053/j.semtcvs.2022.06.003. Epub 2022 Jun 13.
7
Clinicopathologic and Genotypic Features of Lung Adenocarcinoma Characterized by the International Association for the Study of Lung Cancer Grading System.以国际肺癌研究协会分级系统为特征的肺腺癌的临床病理和基因特征
J Thorac Oncol. 2022 May;17(5):700-707. doi: 10.1016/j.jtho.2022.02.005. Epub 2022 Feb 25.
8
Prognostic and predictive value of the newly proposed grading system of invasive pulmonary adenocarcinoma in Chinese patients: a retrospective multicohort study.新提出的中国浸润性肺腺癌分级系统的预后和预测价值:一项回顾性多队列研究。
Mod Pathol. 2022 Jun;35(6):749-756. doi: 10.1038/s41379-021-00994-5. Epub 2022 Jan 10.
9
Updates in grading and invasion assessment in lung adenocarcinoma.肺腺癌分级和侵袭评估的新进展。
Mod Pathol. 2022 Jan;35(Suppl 1):28-35. doi: 10.1038/s41379-021-00934-3. Epub 2021 Oct 6.
10
Clinicopathological, gene expression and genetic features of stage I lung adenocarcinoma with necrosis.具有坏死的 I 期肺腺癌的临床病理、基因表达和遗传特征。
Lung Cancer. 2021 Sep;159:74-83. doi: 10.1016/j.lungcan.2021.07.001. Epub 2021 Jul 16.